Table 1. Patient Characteristics and Pathologic Outcomesa.
Variable | Intention-to-Treat Population | Per-Protocol Population | |||
---|---|---|---|---|---|
LDG (n = 673) | ODG (n = 686) | LDG (n = 644) | ODG (n = 611) | ||
Age, mean (SD), y | 56.9 (10.9) | 57.5 (11.3) | 56.8 (10.8) | 57.8 (11.2) | |
Sex | |||||
Male | 448 (66.6) | 458 (66.8) | 426 (66.1) | 412 (67.4) | |
Female | 225 (33.4) | 228 (33.2) | 218 (33.9) | 199 (32.6) | |
BMI | 23.8 (2.9) | 23.8 (3.0) | 23.8 (2.9) | 23.8 (3.0) | |
Clinical TNM stageb | |||||
cT1N0M0 | 530 (78.8) | 531 (77.4) | 511 (79.3) | 465 (76.1) | |
cT1N1M0 | 15 (2.2) | 19 (2.8) | 14 (2.2) | 19 (3.1) | |
cT2N0M0 | 128 (19.0) | 136 (19.8) | 119 (18.5) | 127 (20.8) | |
Extent of resectionc | |||||
Distal gastrectomy | 664 (98.7) | 673 (98.1) | 644 (100) | 611 (100) | |
Total gastrectomy | 8 (1.2) | 13 (1.9) | 0 | 0 | |
Extent of lymphadenectomyc | |||||
D1+ | 293 (43.5) | 245 (35.7) | 282 (43.8) | 215 (35.2) | |
D2 | 379 (56.3) | 441 (64.3) | 362 (56.2) | 396 (64.8) | |
No. of retrieved lymph nodes, mean (SD) | 40.5 (15.4) | 43.2 (15.9) | 40.5 (15.5) | 43.6 (15.8) | |
≤15 | 13 (1.9) | 10 (1.5) | 10 (1.6) | 8 (1.3) | |
≥16 | 660 (98.1) | 676 (98.5) | 634 (98.4) | 603 (98.7) | |
Tumor size, mm | 26.7 (17.8) | 27.4 (17.1) | 25.8 (15.1) | 27.0 (16.4) | |
Pathologic T classificationc | |||||
T1 | 548 (81.4) | 549 (80.0) | 531 (82.5) | 485 (79.4) | |
≥T2 | 124 (18.4) | 137 (20.0) | 113 (17.5) | 126 (20.6) | |
Pathologic N classificationc | |||||
N0 | 571 (84.8) | 571 (83.2) | 553 (85.9) | 508 (83.1) | |
N+ | 101 (15.0) | 115 (16.8) | 91 (14.1) | 103 (16.9) | |
Pathologic stage | |||||
I | 583 (86.6) | 579 (84.4) | 567 (88.0) | 516 (84.5) | |
II | 60 (8.9) | 75 (10.9) | 52 (8.1) | 66 (10.8) | |
III | 29 (4.3) | 32 (4.7) | 25 (3.9) | 29 (4.7) | |
IV | 1 (0.1) | 0 | 0 | 0 |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); LDG, laparoscopic distal gastrectomy, ODG, open distal gastrectomy.
Data are presented as number (percentage) of patients unless otherwise indicated.
The TNM stage was determined according to the seventh edition of the American Joint Committee on Cancer/Union for International Cancer Control Cancer Staging Manual.
One patient who did not undergo gastrectomy because of carcinomatosis was excluded from the LDG group.